Navigation Links
Blood Thinners May Boost Survival for Prostate Cancer Patients: Study
Date:2/21/2013

By Denise Mann
HealthDay Reporter

THURSDAY, Feb. 21 (HealthDay News) -- Men with advanced prostate cancer might live longer when they are taking blood-thinning medication, a small study suggests.

Prostate cancer patients who were also taking a blood thinner, usually to stave off a blood clot, had a 39 percent increase in overall survival over men who were not taking these drugs, report researchers from the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore.

But the study authors and outside experts caution that blood thinners can't be prescribed routinely to cancer patients, as they confer risks including bleeding, although men who need an anticoagulant might also find it beneficial in terms of prostate cancer. The findings were presented this month by Caroline Pratz and colleagues at an American Society of Clinical Oncology (ASCO) conference in Orlando, Fla.

The U.S. National Cancer Institute estimates that this year almost 239,000 new cases of prostate cancer will be diagnosed in the United States, and nearly 30,000 men will die from the disease.

The new study included almost 250 men with advanced or spreading prostate cancer who were receiving chemotherapy. Of these, 11.7 percent were also taking a blood thinner to prevent potentially fatal blood clots that could detach and reach their lungs, known as a pulmonary embolism. The men taking blood thinners -- heparin and warfarin were included -- survived for about 21 months, compared to slightly more than 17 months for men who were not taking blood thinners.

The finding was surprising, because the researchers thought venous thromboembolism -- clots deep in the leg veins -- would negatively affect overall survival.

But how or even if the blood-thinning medications could confer a survival edge is unknown. The study only shows an association, it does not show that it's the blood thinners themselves that made the difference, said Dr. Cy Stein, an oncologist at the City of Hope Medical Center in Duarte, Calif., who was not involved with the study.

"Maybe men who develop blood clots have something else that affects how they respond to chemotherapy. We just don't know," Stein said.

Another expert said this is not the first time that blood thinners, including aspirin (which was not included in the new study), have been linked to improved survival for men with prostate cancer.

"Most of the data comes out of studies where oncology patients are being treated with blood thinners to prevent blood clots and incidentally there was some improvement in survival," said Dr. Manish Vira, director of the fellowship program in urologic oncology at North Shore-LIJ's Arthur Smith Institute for Urology in Lake Success, N.Y.

The new findings are "thought-provoking, but we should not just go ahead and treat everyone with cancer with blood thinners based on this study," he said.

Further research is needed, agreed Dr. Eric Singer, a urologic oncologist at the Cancer Institute of New Jersey and assistant professor of surgery at UMDNJ-Robert Wood Johnson Medical School in New Brunswick, N.J. "There is evidence from a number of studies suggesting that blood thinners might interact in some different ways with cancer and its treatment," Singer said.

"The guys who were getting [blood thinners] did better and something could be going on there, but keep in mind that being on a blood thinner comes with a risk of bleeding and stroke and should not be used lightly," Singer added.

More work is needed to confirm the results, and then to determine the ideal anticoagulant as well as the dose, timing and related risks, the study authors said.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCES: Cy A. Stein, M.D., Ph.D., Arthur and Rosalie Kaplan Professor and chair, department of medical oncology and experimental therapeutics and deputy director of clinical research, City of Hope Medical Center, Duarte, Calif.; Manish A. Vira, director, fellowship program in urologic oncology, North Shore-LIJ Arthur Smith Institute for Urology, Lake Success, N.Y.; Eric A. Singer, M.D., M.A., urologic oncologist, the Cancer Institute of New Jersey and assistant professor of surgery, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, N.J.; presentation, February 2013, American Society of Clinical Oncology conference, Orlando, Fla.


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Save the Date Durand Community Blood Drives at the American Legion with the Rock River Valley Blood Center
2. New Blood Thinner Beats Older Drug for Vein Clots: Study
3. Children’s Cancer & Blood Foundation to Host Private Party at American Girl Place, New York City
4. Damage to Tiny Blood Vessels in Brain May Raise Alzheimers Risk
5. NuvaRing Lawsuit Filed on Behalf of a South Carolina Woman who Developed Two Blood Clots While Using NuvaRing, Reports Wright & Schulte LLC
6. US Drug Watchdog Now Urges All DePuy ASR And Pinnacle All Metal Hip Implant Recipients To Get A Blood Test And To Call Them Before The Time Runs Out To Get Identified
7. STEMSOFT and The Canadian Blood and Marrow Transplant Group Announce Partnership
8. High Blood Pressure in Pregnancy May Predict Later Ills, Study Says
9. NuvaRing Blood-Clotting Victims Still Eligible to File Lawsuits Through Resource4thePeople
10. Blood-based test detects cancer earlier, from the February 2013 Harvard Health Letter
11. Scientists discover protein that allows safe recycling of iron from old red blood cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Thinners May Boost Survival for Prostate Cancer Patients: Study
(Date:1/20/2017)... ... ... Angel”: a heartwarming and earnest tale of faith and believing in the path ... the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, alumnus of The ... of her new book, Marjorie says, “‘The Angel’ was written as a fairytale, but ...
(Date:1/20/2017)... ... January 20, 2017 , ... D R ... Pressure (OPEP) device, was featured in a study indicating superior performance against competitive ... “Analysis of Three Oscillating Positive Expiratory Pressure Devices During Simulated Breathing“ was ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “Knowledge is God’s ... guided by faith. “Knowledge is God’s Lighthouse” is the creation of published author, Gene ... novels, and poetry collections. , “I have been writing since high school and ...
(Date:1/19/2017)... ... January 20, 2017 , ... Today, the Centers for ... in four of CMS’s Alternative Payment Models (APMs) in 2017. Clinicians who participate in ... APMs are an important part of the Administration’s effort to build a system that ...
(Date:1/19/2017)... ... January 19, 2017 , ... Wells Pharmacy ... enhancement of their 503A compounding pharmacy located in Ocala, Florida. , Meeting ... and patients throughout the United States for high-quality human anti-aging and wellness ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017   Science Exchange ... excited to announce that the first five replication ...  (RP:CB) have been published in eLife today. Despite ... represents the first practical evaluation of reproducibility rates ... reproducible studies. Unlike other assessments of reproducibility, the ...
(Date:1/19/2017)... January 18, 2017 , , Marks E-QURE ... distribution agreement, following similar agreements in Israel ... Wound care is $2 5 billion ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of ... Médica Equipos Médicos S.A.S. (TeckMedica) in Colombia for the ...
(Date:1/19/2017)... The drug delivery technology market is projected ... 1,179.20 billion in 2016, at a CAGR of 7.2% ... diseases, increasing demand for biologics, technological advancements, and new ... this market. Whereas, self-administration & home care and rising ... opportunities for players operating in this market. On the ...
Breaking Medicine Technology: